LEADER 01186nam--2200385---450- 001 990001227200203316 005 20060130091711.0 035 $a000122720 035 $aUSA01000122720 035 $a(ALEPH)000122720USA01 035 $a000122720 100 $a20031029d1972----km-y0itay0103----ba 101 0 $aeng 102 $aUK 105 $aa|||||||001yy 200 1 $a<> history of keyboard music to 1700$fWilli Apel$gtranslated and revised by Hans Tischler 210 $aBloomington$cIndiana University Press$d1972 215 $aXVI, 977 p.$cill.$d23 cm 410 0$12001 454 1$12001 461 1$1001-------$12001 606 0 $aStrumenti a tastiera$xStoria$zOrigini-1700 700 1$aAPEL,$bWilli$0459012 702 1$aTISCHLER,$bHans 801 0$aIT$bsalbc$gISBD 912 $a990001227200203316 951 $aXIII.3.C. 94(VII-M-174)$b77532 L.M.$cVII-M 959 $aBK 969 $aUMA 979 $aSIAV7$b10$c20031029$lUSA01$h1518 979 $aSIAV7$b10$c20031029$lUSA01$h1519 979 $aPATRY$b90$c20040406$lUSA01$h1728 979 $aCOPAT5$b90$c20060130$lUSA01$h0917 996 $aHistory of keyboard music to 1700$9984683 997 $aUNISA LEADER 04147oam 2200577 450 001 9910555136903321 005 20220808193447.0 010 $a1-119-35612-1 010 $a1-119-35619-9 010 $a1-119-35611-3 035 $a(CKB)4950000000162532 035 $a(OCoLC)1127947568 035 $a(MiAaPQ)EBC5977949 035 $a(EXLCZ)994950000000162532 100 $a20191211h20202020 uy 0 101 0 $aeng 135 $aurcn#|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aPharmaceutical microbiological quality assurance and control $epractical guide for non-sterile manufacturing /$fedited by David Roesti, Novartis Pharma Stein AG, Switzerland, Marcel Goverde, MGP Consulting GmbH, Switzerland 210 1$aHoboken, NJ :$cWiley,$d2020. 210 4$dİ2020 215 $a1 online resource (xxxv, 546 pages) $cillustrations 215 $a1 online resource (xxxv, 546 pages) $cillustrations 311 1 $a1-119-35607-5 311 08$aPrint version: Pharmaceutical microbiological quality assurance and control. First edition. Hoboken, NJ : Wiley, 2019 9781119356073 1119356075 (DLC) 2019024995 (OCoLC)1039613996 320 $aIncludes bibliographical references and index. 327 $aMicrobiological control strategy -- Microbial contamination risk assessment in non-sterile drug product manufacturing and risk mitigation -- Qualification of Microbiological laboratory personnel and equipment -- Introduction to culture media in pharmaceutical microbiology for non-sterile products -- Microbiological examination of non-sterile final dosage forms and raw material including acceptance criteria and testing frequency -- Microbial requirements and testing of primary packaging -- Utilities design and testing -- Microbiological Environmental Monitoring -- Identification of microorganisms -- Calculating alert levels and trending of microbiological data -- Exclusion of objectionable microorganisms from non-sterile pharmaceutical drug products -- Data integrity and microbiological excursion handling -- Rapid microbiological methods -- Validation of a rapid microbiological method for the microbiological examination of non-sterile and non-filterable drug products, APIs and excipients -- An Ex-Regulator's View of the Microbiology QA/QC Functions in the US Pharmaceutical Industries -- Practical guide for microbiological QA/QC of non-sterile pharmaceuticals manufacturing for EU -- Which microbiological tests can better be performed in-house and what can be easily outsourced. 330 $a"This book provides a thorough and modern approach to controlling and monitoring microbial contaminations during the manufacturing of non-sterile pharmaceuticals. It covers state-of-the-art microbiology quality assurance and control (QA / QC) tests as well as risk mitigation strategies so that the reader can implement these methodologies in a facility or laboratory to meet microbiology current good manufacturing practices (cGMPs). Also, the authors discuss developments in microbiological testing technology. They share their long experience in practicing microbiological QA/QC in large multinational pharmaceutical companies and present real-life complex cases involving tough decision making"--. 606 $aPharmaceutical technology$xStandards 606 $aMicrobiological Techniques$xstandards 606 $aMicrobiological Phenomena 606 $aDrugs$xTesting$2fast$3(OCoLC)fst00898940 606 $aPharmaceutical chemistry$2fast$3(OCoLC)fst01060115 608 $aElectronic books. 615 0$aPharmaceutical technology$xStandards. 615 2$aMicrobiological Techniques$xstandards. 615 2$aMicrobiological Phenomena. 615 7$aDrugs$xTesting. 615 7$aPharmaceutical chemistry. 676 $a615.19 702 $aRoesti$b David$f1973-, 702 $aGoverde$b Marcel$f1967-, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910555136903321 996 $aPharmaceutical microbiological quality assurance and control$92815510 997 $aUNINA LEADER 01086nam 2200337 n 450 001 996391740803316 005 20221102113537.0 035 $a(CKB)1000000000663471 035 $a(EEBO)2240936860 035 $a(UnM)9959339700971 035 $a(EXLCZ)991000000000663471 100 $a20791123d1750 uy 101 0 $aeng 135 $aurbn||||a|bb| 200 04$aThe case of the inhabitants of the town of Parshore in the county of Worcester$b[electronic resource] 210 $a[Worcester? $cs.n.$d1750?] 215 $a1 sheet ([1] p.) 300 $aReproduction of original in the British Library. 300 $aWith a docket title. 330 $aeebo-0018 606 $aRoads$zEngland$vEarly works to 1800 607 $aWorcestershire (England)$xHistory$y18th century$vEarly works to 1800 615 0$aRoads 801 0$bUk-ES 801 1$bUk-ES 801 2$bCStRLIN 801 2$bCu-RivES 906 $aBOOK 912 $a996391740803316 996 $aThe case of the inhabitants of the town of Parshore in the county of Worcester$92335484 997 $aUNISA